fbpx

Health Care

Savient Pharmaceuticals files for bankruptcy

The sale will be conducted under bankruptcy court-supervised auction process, Savient said in a news release. The agreement with Sloan sets the floor, or minimum acceptable bid, and can be topped. Savient assets include gout drug Krystexxa, which gained regulatory approval in 2010. Krystexxa treats refractory chronic gout, a rare condition the company estimates affects ...

Read More »

Obamacare compliance focus of upcoming NJBIA seminar

The NJBIA expects a strong turnout at its Oct. 30 seminar on the Affordable Care Act, which will be held from 8:30 a.m. to 1 p.m. at the Pines Manor in Edison. Christine Stearns, vice president for health and legal affairs at NJBIA, said many employers are now entering the opening enrollment period for group ...

Read More »

Expanded AmeriHealth Medicare Advantage now covers 17 N.J. counties

AmeriHealth said individuals already covered by AmeriHealth’s Medicare Advantage HMO Plan in the original five counties will see a premium decrease. “We are always looking for new ways to offer the people of our state affordable, quality options,” said Mike Munoz, senior vice president of sales and marketing. “We saw an opportunity to increase access ...

Read More »

Emergency Medical Associates reports record growth

Since April 2012, EMA said it has grown its client base from 19 emergency departments to 28 emergency departments in New Jersey, New York, North Carolina and Rhode Island and increased its annual ED patient visits to nearly 1.4 million.“It’s an exciting time in our history,” said Dr. Raymond Iannaccone, president and chief executive officer. ...

Read More »

C.R. Bard announces dividend

According to the announcement, the current indicated annual dividend rate is 84 cents per share. The dividend is payable on November 1, 2013 to shareholders of record at the close of business on October 21, 2013. The company has recently announced it will acquire both Rochester Medical and Medafor. Bard has also sold more than ...

Read More »

Bayer gets FDA approval for Adempas

The FDA reviewed Adempas under its priority review program, which provides an expedited six-month review for drugs that promise major advances in treatment. Pulmonary hypertension is caused by abnormally high blood pressure in the arteries of the lungs, making the right side of the heart work harder than normal, according to the FDA. The condition ...

Read More »

Covance announces 250M debt financing

According to the announcement, the notes are expected to be issued in November 2013 in the following four series:– $15 million bearing interest at 3.25% and maturing on November 15, 2018;– $50 million bearing interest at 3.90% and maturing on November 15, 2020;– $90 million bearing interest at 4.50% and maturing on November 15, 2023; ...

Read More »

Robert Wood Johnson, Rutgers to create unique ACO

The ACO, called Robert Wood Johnson Partners, plans to launch in January of 2014. Dr. Alfred Tallia, chair of the department of family medicine and community health at Rutgers – Robert Wood Johnson Medical School, will be the executive director. Created by the Affordable Care Act, Medicare ACOs reward hospitals and doctors that deliver high-quality, ...

Read More »

Quest Diagnostics acquires ConVerge

According to the announcement, the transaction includes ConVerge’s laboratory in Peabody, Massachusetts, and its patient service centers operating in Massachusetts, New Hampshire and Connecticut. ConVerge will operate as a wholly-owned subsidiary of Quest Diagnostics and its laboratory will operate as part of Quest Diagnostics’ national laboratory network. Over time, the ConVerge laboratory is expected to ...

Read More »

WIRB-Copernicus Group names new chief research officer

According to the announcement, for more than 13 years, Dr. McNair has been actively involved with institutional review boards. Prior to joining WCG, she acted as a consultant to pharmaceutical and biotechnology companies, providing medical guidance on clinical development strategies and designs for new drug studies, as well as handling medical oversight of all phases ...

Read More »